【JCI colloidal iodine】

Comprehensive Medicine and Colloidal Iodine

Modern medicine mainly focuses on "symptomatic treatment" hoping for the medicinal effects of medicines, but there are also "fundamental therapies" or "treatment methods" that enhance the human body's natural immunity and draw out the natural healing power. "Causal therapy" is getting a lot of attention.
JCI MN colloidal iodine (C.I.M.N.) is highly effective in revitalizing metabolism, boosting immunity and bringing out the natural healing power of the body, and it works to improve the following medical conditions
  • Various cancers, including terminal cancer
  • Vascular disorders (brain, heart, etc.)
  • Autoimmune and allergic diseases
  • Viral diseases (including AIDS)
  • Epilepsy and other brain disorders
  • Diabetes, Kidney Disease
  • Other intractable diseases

In addition to these, it can be expected to help maintain health and prevent disease.

Superior efficacy and safety

Many cancer patients (mostly terminal) and patients with other diseases have made dramatic recoveries with JCI MN colloidal iodine (C.I.M.N.). It also has fewer side effects, as shown in the table below, as a disadvantage of previous treatments, and its safety has been confirmed by nearly a decade of treatment experience. In recent years, as more physicians have become interested in the efficacy of JCI MN colloidal iodine (C.I.M.N.), its use by physicians and medical professionals has increased, with remarkable recovery results for the treatment of cancer, vascular disease and other medical conditions.
Conventional Cancer Treatment Disadvantages
Surgery If there's a lot of damage to the body and there are cancer cells in other places, there's a chance of recurrence.
chemotherapy It can't be cured alone and is often accompanied by side effects.
Radiation Therapy Some types of cancer don't respond well to radiation.

Advantages of JCI MN colloidal iodine (C.I.M.N)

  • It can only kill cancer cells.

  • It does not harm normal cells. Rather, it activates them.

  • Fewer side effects (drug damage)

  • It's not resistant.

  • It's not accumulative in the body.

As mentioned above, JCI MN colloidal iodine (C.I.M.N.) can only kill cancer cells and does not harm normal cells and also activates them.
They have fewer side effects and are not tolerated or accumulated in the body.

On the other hand, cancer cells become resistant to anti-cancer drugs and other substances.

JCI MN colloidal iodine (C.I.M.N.) is also not cumulative in the body.
The duration of action in the body is 2 hours, after which it is eliminated from the body with the urine.
While it is preferable to take M.N. every two hours, it does not accumulate in the body and is safe.

On the other hand, depending on the type of cancer drug, it may take up to two years for the drug to be safely eliminated from the body.

Reactions during treatment

Various cancers, including terminal cancerVascular disorders (brain, heart, etc.)Autoimmune and allergic diseases
Viral diseases (including AIDS)Epilepsy and other brain disordersDiabetes, Kidney Disease
Other intractable diseasesOther benefits such as health maintenance and disease prevention can be expected.

How to administer JCI MN colloidal iodine (C.I.M.N)

Depending on the patient's medical condition, a combination of the following methods will be administered

• medicine taken internally
JCI MN colloidal iodine (C.I.M.N.) is basically taken orally (30 ml/dose).
The oral JCI MN colloidal iodine (C.I.M.N.) is available in two types: regular colloidal iodine oral solution and a thinly concentrated prophylactic oral solution designed to prevent disease and recurrence.

• Intravascular injection/infusion
Injections and infusions are particularly effective for leukemia and terminal cancer.
They are also suitable for patients with esophageal and gastric cancers who have difficulty taking the drug orally or who want a short-term therapeutic effect.

• inhalation
JCI MN colloidal iodine (C.I.M.N.) is made into a mist and inhaled using an inhaler.
It is effective for patients with lung cancer and bronchial asthma.

Other methods are in the research stage, including
Intrathoracic, intra-abdominal injection (pleural and ascites)Implantation (e.g., rectal cancer)Intravaginal injection (cervical cancer)
In-bladder injection (bladder cancer)bureau injection